INOINOVIO PHARMACEUTICALS, INC.

Nasdaq inovio.com


$ 6.57 $ 0.04 (0.61 %)    

Thursday, 12-Sep-2024 12:15:02 EDT
QQQ $ 469.73 $ 1.10 (0.23 %)
DIA $ 408.78 $ -0.68 (-0.17 %)
SPY $ 555.20 $ 0.21 (0.04 %)
TLT $ 99.89 $ -0.48 (-0.48 %)
GLD $ 235.25 $ 0.61 (0.26 %)
$ 6.55
$ 6.53
-- x --
-- x --
$ 6.53 - $ 6.63
$ 3.89 - $ 14.75
197,736
na
170.07M
$ 0.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-06-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-12-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-14-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-08-2016 06-30-2016 10-Q
34 05-09-2016 03-31-2016 10-Q
35 03-14-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

 - Reuters

Core News & Articles

https://www.nbcnews.com/health/health-news/us-prepares-possible-arrival-severe-strain-mpox-rcna169926 Senior Biden administrati...

Core News & Articles

https://ec.europa.eu/commission/presscorner/detail/en/ip_24_4523 Today, close to 100,000 mpox vaccine doses will arrive in the ...

Core News & Articles

- Reuters

Core News & Articles

https://www.reviewjournal.com/life/health/mpox-case-reported-at-clark-county-detention-center-3148320/ One case of mpox has bee...

Core News & Articles

- Reuters 

Core News & Articles

https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-member-states-information-sessio...

Core News & Articles

https://www.fox2detroit.com/news/mpox-wayne-county-health-department-confirms-first-case-since-2022?taid=66c643be103e400001efc3...

Core News & Articles

- Reuters 

Core News & Articles

- Reuters

Core News & Articles

- Reuters

Core News & Articles

- Reuters

Core News & Articles

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Core News & Articles

https://x.com/i/broadcasts/1kvJpbgRNWgKE

Core News & Articles

- Director General

 oppenheimer-maintains-outperform-on-inovio-pharmaceuticals-lowers-price-target-to-33

Oppenheimer analyst Jay Olson maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Outperform and lowers the price target fr...

 rbc-capital-maintains-sector-perform-on-inovio-pharmaceuticals-lowers-price-target-to-8

RBC Capital analyst Gregory Renza maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and lowers the price t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION